These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20955432)

  • 1. Impact of innate inflammation in population studies.
    Elkind MS
    Ann N Y Acad Sci; 2010 Oct; 1207():97-106. PubMed ID: 20955432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, atherosclerosis, and stroke.
    Elkind MS
    Neurologist; 2006 May; 12(3):140-8. PubMed ID: 16688015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein, stroke, and statins.
    Angerio AD; Bialko MF; White BM
    Crit Care Nurs Q; 2007; 30(2):161-5. PubMed ID: 17356357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
    Clearfield MB
    J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral vessel disease and inflammatory process].
    Kitagawa K
    Brain Nerve; 2009 Sep; 61(9):1061-8. PubMed ID: 19803405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.
    Welsh P; Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ
    Cerebrovasc Dis; 2009; 27(3):247-53. PubMed ID: 19176958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
    Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
    Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atherosclerosis and inflammation: the role of C-reactive protein].
    Ablij HC; Meinders AE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):15-20. PubMed ID: 12564292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events.
    Futterman LG; Lemberg L
    Am J Crit Care; 2002 Sep; 11(5):482-6. PubMed ID: 12233975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2 and risk of stroke.
    Gorelick PB
    Am J Cardiol; 2008 Jun; 101(12A):34F-40F. PubMed ID: 18549870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke.
    Silvestri A; Vitale C; Ferretti F; Onorati D; Fini M; Rosano GM
    J Am Geriatr Soc; 2004 Sep; 52(9):1586-7. PubMed ID: 15341576
    [No Abstract]   [Full Text] [Related]  

  • 16. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of C-reactive protein in stroke prevention: bright and dark sides of the moon.
    Di Napoli M; Papa F
    Expert Rev Neurother; 2004 Jul; 4(4):613-22. PubMed ID: 15853580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Szarek M; Waters DD; Libby P; Ganz P;
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):142-7. PubMed ID: 17991875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.